(Q46580006)

23 December 2017

title

Prostate cancer: Predicting response to androgen receptor signalling inhibition (English)

1 reference

23 December 2017

author name string

Christopher P Evans

series ordinal

1

1 reference

23 December 2017

Primo N Lara

series ordinal

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

22 July 2014

1 reference

23 December 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

Nature Reviews Urology

1 reference

23 December 2017

volume

11

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

433-435

1 reference

23 December 2017

Increased survival with enzalutamide in prostate cancer after chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

NF-κB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Can targeting the androgen receptor in localized prostate cancer provide insights into why men with metastatic castration-resistant prostate cancer die?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.179

Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25048863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2014.179

1 reference

23 December 2017

1 reference

23 December 2017